Vigabatrin and Insulin Sensitivity
Conditions: NAFLD; Obesity Interventions: Drug: Vigabatrin; Drug: Placebo oral tablet Sponsor: Washington University School of Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 25, 2020 Category: Research Source Type: clinical trials
Pregnancy Outcomes and Maternal Insulin Sensitivity
Conditions: Gestational Diabetes; Other " Heavy-For-Dates " Infants; Small for Gestational Age Infant; Diabetes Mellitus, Type 2 Intervention: Diagnostic Test: meal tolerance test Sponsor: University Medical Center Groningen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials
The Effect of Curcumin on the Development of Prednisolone-induced Hepatic Insulin Resistance
Conditions: Insulin Resistance; Non-Alcoholic Fatty Liver Disease Interventions: Drug: Curcumin Liposome; Drug: Prednisolone; Drug: Placebos Sponsor: University Hospital, Gentofte, Copenhagen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials
Effect of Serum LDL Cholesterol Concentration on Pancreatic Insulin Secretion
Conditions: Hypercholesterolemia; Insulin Resistance; Insulin Secretion Intervention: Drug: Lowering cholesterol concentrations by PCSK-9 inhibitor Sponsor: University Hospital Tuebingen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials
Pregnancy Outcomes and Maternal Insulin Sensitivity
Conditions: Gestational Diabetes; Other " Heavy-For-Dates " Infants; Small for Gestational Age Infant; Diabetes Mellitus, Type 2 Intervention: Diagnostic Test: meal tolerance test Sponsor: University Medical Center Groningen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials
The Effect of Curcumin on the Development of Prednisolone-induced Hepatic Insulin Resistance
Conditions: Insulin Resistance; Non-Alcoholic Fatty Liver Disease Interventions: Drug: Curcumin Liposome; Drug: Prednisolone; Drug: Placebos Sponsor: University Hospital, Gentofte, Copenhagen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials
Effect of Serum LDL Cholesterol Concentration on Pancreatic Insulin Secretion
Conditions: Hypercholesterolemia; Insulin Resistance; Insulin Secretion Intervention: Drug: Lowering cholesterol concentrations by PCSK-9 inhibitor Sponsor: University Hospital Tuebingen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials
Pregnancy Outcomes and Maternal Insulin Sensitivity
Conditions: Gestational Diabetes; Other " Heavy-For-Dates " Infants; Small for Gestational Age Infant; Diabetes Mellitus, Type 2 Intervention: Diagnostic Test: meal tolerance test Sponsor: University Medical Center Groningen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials
The Effect of Curcumin on the Development of Prednisolone-induced Hepatic Insulin Resistance
Conditions: Insulin Resistance; Non-Alcoholic Fatty Liver Disease Interventions: Drug: Curcumin Liposome; Drug: Prednisolone; Drug: Placebos Sponsor: University Hospital, Gentofte, Copenhagen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials
Effect of Serum LDL Cholesterol Concentration on Pancreatic Insulin Secretion
Conditions: Hypercholesterolemia; Insulin Resistance; Insulin Secretion Intervention: Drug: Lowering cholesterol concentrations by PCSK-9 inhibitor Sponsor: University Hospital Tuebingen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials
Pregnancy Outcomes and Maternal Insulin Sensitivity
Conditions: Gestational Diabetes; Other " Heavy-For-Dates " Infants; Small for Gestational Age Infant; Diabetes Mellitus, Type 2 Intervention: Diagnostic Test: meal tolerance test Sponsor: University Medical Center Groningen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials
The Effect of Curcumin on the Development of Prednisolone-induced Hepatic Insulin Resistance
Conditions: Insulin Resistance; Non-Alcoholic Fatty Liver Disease Interventions: Drug: Curcumin Liposome; Drug: Prednisolone; Drug: Placebos Sponsor: University Hospital, Gentofte, Copenhagen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials
Effect of Serum LDL Cholesterol Concentration on Pancreatic Insulin Secretion
Conditions: Hypercholesterolemia; Insulin Resistance; Insulin Secretion Intervention: Drug: Lowering cholesterol concentrations by PCSK-9 inhibitor Sponsor: University Hospital Tuebingen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials
Pregnancy Outcomes and Maternal Insulin Sensitivity
Conditions: Gestational Diabetes; Other " Heavy-For-Dates " Infants; Small for Gestational Age Infant; Diabetes Mellitus, Type 2 Intervention: Diagnostic Test: meal tolerance test Sponsor: University Medical Center Groningen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials
The Effect of Curcumin on the Development of Prednisolone-induced Hepatic Insulin Resistance
Conditions: Insulin Resistance; Non-Alcoholic Fatty Liver Disease Interventions: Drug: Curcumin Liposome; Drug: Prednisolone; Drug: Placebos Sponsor: University Hospital, Gentofte, Copenhagen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials
Effect of Serum LDL Cholesterol Concentration on Pancreatic Insulin Secretion
Conditions: Hypercholesterolemia; Insulin Resistance; Insulin Secretion Intervention: Drug: Lowering cholesterol concentrations by PCSK-9 inhibitor Sponsor: University Hospital Tuebingen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials
Pregnancy Outcomes and Maternal Insulin Sensitivity
Conditions: Gestational Diabetes; Other " Heavy-For-Dates " Infants; Small for Gestational Age Infant; Diabetes Mellitus, Type 2 Intervention: Diagnostic Test: meal tolerance test Sponsor: University Medical Center Groningen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials
The Effect of Curcumin on the Development of Prednisolone-induced Hepatic Insulin Resistance
Conditions: Insulin Resistance; Non-Alcoholic Fatty Liver Disease Interventions: Drug: Curcumin Liposome; Drug: Prednisolone; Drug: Placebos Sponsor: University Hospital, Gentofte, Copenhagen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials
Effect of Serum LDL Cholesterol Concentration on Pancreatic Insulin Secretion
Conditions: Hypercholesterolemia; Insulin Resistance; Insulin Secretion Intervention: Drug: Lowering cholesterol concentrations by PCSK-9 inhibitor Sponsor: University Hospital Tuebingen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials
Pregnancy Outcomes and Maternal Insulin Sensitivity
Conditions: Gestational Diabetes; Other " Heavy-For-Dates " Infants; Small for Gestational Age Infant; Diabetes Mellitus, Type 2 Intervention: Diagnostic Test: meal tolerance test Sponsor: University Medical Center Groningen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials
The Effect of Curcumin on the Development of Prednisolone-induced Hepatic Insulin Resistance
Conditions: Insulin Resistance; Non-Alcoholic Fatty Liver Disease Interventions: Drug: Curcumin Liposome; Drug: Prednisolone; Drug: Placebos Sponsor: University Hospital, Gentofte, Copenhagen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials
Effect of Serum LDL Cholesterol Concentration on Pancreatic Insulin Secretion
Conditions: Hypercholesterolemia; Insulin Resistance; Insulin Secretion Intervention: Drug: Lowering cholesterol concentrations by PCSK-9 inhibitor Sponsor: University Hospital Tuebingen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials
Pregnancy Outcomes and Maternal Insulin Sensitivity
Conditions: Gestational Diabetes; Other " Heavy-For-Dates " Infants; Small for Gestational Age Infant; Diabetes Mellitus, Type 2 Intervention: Diagnostic Test: meal tolerance test Sponsor: University Medical Center Groningen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials
The Effect of Curcumin on the Development of Prednisolone-induced Hepatic Insulin Resistance
Conditions: Insulin Resistance; Non-Alcoholic Fatty Liver Disease Interventions: Drug: Curcumin Liposome; Drug: Prednisolone; Drug: Placebos Sponsor: University Hospital, Gentofte, Copenhagen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials
Effect of Serum LDL Cholesterol Concentration on Pancreatic Insulin Secretion
Conditions: Hypercholesterolemia; Insulin Resistance; Insulin Secretion Intervention: Drug: Lowering cholesterol concentrations by PCSK-9 inhibitor Sponsor: University Hospital Tuebingen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials
Pregnancy Outcomes and Maternal Insulin Sensitivity
Conditions: Gestational Diabetes; Other " Heavy-For-Dates " Infants; Small for Gestational Age Infant; Diabetes Mellitus, Type 2 Intervention: Diagnostic Test: meal tolerance test Sponsor: University Medical Center Groningen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials
The Effect of Curcumin on the Development of Prednisolone-induced Hepatic Insulin Resistance
Conditions: Insulin Resistance; Non-Alcoholic Fatty Liver Disease Interventions: Drug: Curcumin Liposome; Drug: Prednisolone; Drug: Placebos Sponsor: University Hospital, Gentofte, Copenhagen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials
Effect of Serum LDL Cholesterol Concentration on Pancreatic Insulin Secretion
Conditions: Hypercholesterolemia; Insulin Resistance; Insulin Secretion Intervention: Drug: Lowering cholesterol concentrations by PCSK-9 inhibitor Sponsor: University Hospital Tuebingen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials
Pregnancy Outcomes and Maternal Insulin Sensitivity
Conditions: Gestational Diabetes; Other " Heavy-For-Dates " Infants; Small for Gestational Age Infant; Diabetes Mellitus, Type 2 Intervention: Diagnostic Test: meal tolerance test Sponsor: University Medical Center Groningen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials
The Effect of Curcumin on the Development of Prednisolone-induced Hepatic Insulin Resistance
Conditions: Insulin Resistance; Non-Alcoholic Fatty Liver Disease Interventions: Drug: Curcumin Liposome; Drug: Prednisolone; Drug: Placebos Sponsor: University Hospital, Gentofte, Copenhagen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials
Effect of Serum LDL Cholesterol Concentration on Pancreatic Insulin Secretion
Conditions: Hypercholesterolemia; Insulin Resistance; Insulin Secretion Intervention: Drug: Lowering cholesterol concentrations by PCSK-9 inhibitor Sponsor: University Hospital Tuebingen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials
Pregnancy Outcomes and Maternal Insulin Sensitivity
Conditions: Gestational Diabetes; Other " Heavy-For-Dates " Infants; Small for Gestational Age Infant; Diabetes Mellitus, Type 2 Intervention: Diagnostic Test: meal tolerance test Sponsor: University Medical Center Groningen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials
The Effect of Curcumin on the Development of Prednisolone-induced Hepatic Insulin Resistance
Conditions: Insulin Resistance; Non-Alcoholic Fatty Liver Disease Interventions: Drug: Curcumin Liposome; Drug: Prednisolone; Drug: Placebos Sponsor: University Hospital, Gentofte, Copenhagen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials
Effect of Serum LDL Cholesterol Concentration on Pancreatic Insulin Secretion
Conditions: Hypercholesterolemia; Insulin Resistance; Insulin Secretion Intervention: Drug: Lowering cholesterol concentrations by PCSK-9 inhibitor Sponsor: University Hospital Tuebingen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials
Pregnancy Outcomes and Maternal Insulin Sensitivity
Conditions: Gestational Diabetes; Other " Heavy-For-Dates " Infants; Small for Gestational Age Infant; Diabetes Mellitus, Type 2 Intervention: Diagnostic Test: meal tolerance test Sponsor: University Medical Center Groningen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials
The Effect of Curcumin on the Development of Prednisolone-induced Hepatic Insulin Resistance
Conditions: Insulin Resistance; Non-Alcoholic Fatty Liver Disease Interventions: Drug: Curcumin Liposome; Drug: Prednisolone; Drug: Placebos Sponsor: University Hospital, Gentofte, Copenhagen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials
Pregnancy Outcomes and Maternal Insulin Sensitivity
Conditions: Gestational Diabetes; Other " Heavy-For-Dates " Infants; Small for Gestational Age Infant; Diabetes Mellitus, Type 2 Intervention: Diagnostic Test: meal tolerance test Sponsor: University Medical Center Groningen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials
The Effect of Curcumin on the Development of Prednisolone-induced Hepatic Insulin Resistance
Conditions: Insulin Resistance; Non-Alcoholic Fatty Liver Disease Interventions: Drug: Curcumin Liposome; Drug: Prednisolone; Drug: Placebos Sponsor: University Hospital, Gentofte, Copenhagen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials
Studying the Effect of Mediterranean Diet on Insulin Resistance Among Obese Children and Adolescents
Conditions: Obesity, Childhood; Insulin Resistance Intervention: Other: the effect of Mediterranean diet on insulin sensitivity among obese children and adolescents aged Sponsor: University of Jordan Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 18, 2020 Category: Research Source Type: clinical trials
